My watch list
my.bionity.com  
Login  
NEWS
Current news

Watching complex molecules at work

17-Jan-2020 A new method of infrared spectroscopy developed at BESSY II makes single-measurement observation and analysis of very fast as well as irreversible reaction mechanisms in molecules feasible for the first time. Previously, thousands of such reactions have had to be run and measured for this p ... more

Induced pluripotent stem cells for the research of HIV and the innate immune system

17-Jan-2020 Jointly with researchers from Germany and France, researchers of the Paul-Ehrlich-Institut have generated induced pluripotent stem cells from one health individual, one patient with Aicardi-Goutières syndrome, and one patient with Renpenning syndrome. Proteins play a role in both diseases, ... more

Bacteria and sand engineered into living concrete

17-Jan-2020 Cement and concrete haven't changed much as technology in over a hundred years, but researchers in Colorado are revolutionizing building materials by literally bringing them to life. The method developed, presented January 15 in the journal Matter, combines sand and bacteria to build a livi ... more

Washing machine bacteria: the smell comes from the rubber seal

16-Jan-2020 Almost every household in Germany has a washing machine. But what many owners don't realise is that washing machines, which are supposed to clean textiles, can actually be full of germs. Dampness, heat and a large variety of nutrients create ideal living conditions for the growth of bacteri ... more

A key to new drugs

Tiny metal-containing building block might become the core of new drug molecules

16-Jan-2020 A collaboration between research teams in Germany and the USA furnished a new concept for discovering drugs to treat life-threatening illnesses such as cancer, influenza, or multidrug resistant bacteria. The team proposes that three-dimensional metal-containing molecules may function as new ... more

Biologists make living sperm glow

16-Jan-2020 By applying a novel method, biologists at TU Dresden have successfully analysed the metabolism of intact tissues of the fruit fly using a label-free microscopy technique. They used the natural fluorescence of certain metabolic molecules and found that sperm, compared to other tissues, are h ... more

Cunesoft joins forces with Phlexglobal

16-Jan-2020 The Munich-based Cunesoft GmbH, an provider of cloud-based intelligent regulatory data management software and services for the life sciences industry, announced that it has been acquired by Phlexglobal from current investors including Bayern Kapital, High-Tech Gründerfonds and OCCIDENT. Ph ... more

How to make it easier to turn plant waste into biofuels

Innovative process to rapidly dissolve plant fibers

16-Jan-2020 Researchers have developed a new process that could make it much cheaper to produce biofuels such as ethanol from plant waste and reduce reliance on fossil fuels. Their approach, featuring an ammonia-salt based solvent that rapidly turns plant fibers into sugars needed to make ethanol, work ... more

Waters to Acquire Andrew Alliance

15-Jan-2020 Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

First robust cell culture model for the hepatitis E virus

15-Jan-2020 A mutation switches the turbo on during virus replication. This is a blessing for research. Even though hepatitis E causes over three million infections and about 70,000 deaths each year, the virus has been little studied as yet. This may be about to change, because a research team from Boc ... more

All news

Sensing Protein Wellbeing

Molecular probe maps misfolded proteome state in live cells

13-Jan-2020 The folding state of the proteins in live cells often reflect the cell’s general health. Australian scientists have developed a molecular probe that senses the state of the proteome—the entire set of the proteins—by measuring the polarity of the protein environment. The fluorescence signal ... more

Differentiating amino acids: Foundation for direct sequencing of individual proteins developed

19-Dec-2019 A large part of the work inside cells is done by proteins acting as enzymes, transporters, channels, motors, supporting pillars and signaling devices. Proteins are three-dimensionally folded chains of diverse amino acids in a genetically encoded sequence. Whereas scientists have already suc ... more

Virus multiplication in 3D

16-Dec-2019 Vaccinia viruses serve as a vaccine against human smallpox and as the basis of new cancer therapies. Two studies now provide fascinating insights into their unusual propagation strategy at the atomic level. For viruses to multiply, they usually need the support of the cells they infect. In ... more

Predicting a protein's behavior from its appearance

11-Dec-2019 Proteins are the building blocks of life and play a key role in all biological processes. Understanding how they interact with their environment is therefore vital to developing effective therapeutics and the foundation for designing artificial cells. Researchers at the Laboratory of Protei ... more

Fast and cheap low-tech method to test for the presence of any DNA sequence

10-Dec-2019 The student project DipGene developed a new methodology that makes genetic testing as easy as a pH-test. With their simple, cheap and low-tech method to test for the presence of any DNA sequence, they won a prestigious Gold Medal. A student team of the TU Dresden successfully showcased the ... more

Swiss Army Knife for Genome Research

Multifunctional tool CRUP makes enhancer prediction quick and easy

21-Nov-2019 It is the the dream of every molecular geneticist: an easy-to-use program that compares data sets from different cellular conditions, identifies enhancer regions and then assigns them to their target genes. A research team led by Professor Martin Vingron at the Max Planck Institute for Mole ... more

Better biosensor technology created for stem cells

Technology may help guide treatment of Alzheimer's, Parkinson's diseases

13-Nov-2019 A Rutgers-led team has created better biosensor technology that may help lead to safe stem cell therapies for treating Alzheimer's and Parkinson's diseases and other neurological disorders. The technology, which features a unique graphene and gold-based platform and high-tech imaging, monit ... more

Genomic methods and big-data to contain the illegal animal trade

Ark-Biodiversity and HTGF have completed the first joint financing round

29-Oct-2019 Ark-Biodiversity is the newest foundation of the serial entrepreneur Alexander Olek. The 50-year-old father of four children says: “I don’t believe in the survival of humanity without biodiversity; and I do not believe in the conservation of biodiversity, unless our societies find joint mec ... more

Sartorius signs agreement to acquire select Danaher Life Science platform businesses

21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

Sartorius continues on its dynamic growth track

21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

All news on bioanalytics

Bacteria and sand engineered into living concrete

17-Jan-2020 Cement and concrete haven't changed much as technology in over a hundred years, but researchers in Colorado are revolutionizing building materials by literally bringing them to life. The method developed, presented January 15 in the journal Matter, combines sand and bacteria to build a livi ... more

Cunesoft joins forces with Phlexglobal

16-Jan-2020 The Munich-based Cunesoft GmbH, an provider of cloud-based intelligent regulatory data management software and services for the life sciences industry, announced that it has been acquired by Phlexglobal from current investors including Bayern Kapital, High-Tech Gründerfonds and OCCIDENT. Ph ... more

How to make it easier to turn plant waste into biofuels

Innovative process to rapidly dissolve plant fibers

16-Jan-2020 Researchers have developed a new process that could make it much cheaper to produce biofuels such as ethanol from plant waste and reduce reliance on fossil fuels. Their approach, featuring an ammonia-salt based solvent that rapidly turns plant fibers into sugars needed to make ethanol, work ... more

Artificial Muscle Sheets Transform Stem Cells into Bone

Programmable biomaterials for bone regeneration introduced

15-Jan-2020 Specifically programmed materials can, under specific conditions, encourage stem cells to transform into bone cells – as revealed by a German research team under the leadership of the Helmholtz-Zentrum Geesthacht, Centre for Materials and Coastal Research. To do this, the scientists impleme ... more

Molecular factories: The combination between nature and chemistry is functional

13-Jan-2020 Researchers at the University of Basel have succeeded in developing molecular factories that mimic nature. To achieve this they loaded artificial organelles inside micrometer-sized natural blisters (vesicles) produced by cells. These molecular factories remain intact even after injection in ... more

New way to sustainably make chemicals by copying nature's tricks

08-Jan-2020 Researchers have copied the way organisms produce toxic chemicals without harming themselves, paving the way for greener chemical and fuel production. The new technique, pioneered by Imperial College London scientists, could reduce the need to use fossil fuels to create chemicals, plastics, ... more

QIAGEN concludes strategic alternatives review

03-Jan-2020 QIAGEN N.V. announced that it has concluded the previously announced review of potential strategic alternatives, and has determined the execution of its current stand-alone business plan represents the best opportunity to drive future value creation. The Supervisory Board and Management Boa ... more

Novel combination of antibodies leads to significant improvement in cancer immunotherapy

02-Jan-2020 The simultaneous use of antibodies based on two differing mechanisms of action leads to a more effective destruction of tumors. This has been demonstrated by a study in animal models by medical oncologists and scientists at the University of Basel that has been published in the scientific j ... more

Sartorius and the German Research Center for Artificial intelligence launch joint research laboratory

Sartorius-AI-Lab (SAIL) is conducting research into the use of artificial intelligence in Sartorius platform solutions for the biopharmaceutical industry

02-Jan-2020 Sartorius and the German Research Center for Artificial Intelligence (DFKI) have established the Sartorius-AI-Lab (SAIL) research laboratory. On the campus of the DFKI in Kaiserslautern, the use of Artificial Intelligence (AI) in Sartorius product and platform solutions is being experimenta ... more

Merck Licenses Foundational CRISPR Integration Technology to Promega

23-Dec-2019 Merck announced that it has signed a license agreement providing Promega Corp., a global life science manufacturer based in Madison, Wisconsin, USA access to Merck’s foundational CRISPR intellectual property. Promega will use Merck’s CRISPR genome-editing technology to create research produ ... more

All news on biotechnology

A fine sense for molecules

Unique laser technology for the analysis of the molecular composition of biological samples

07-Jan-2020 At the biochemical level, organisms can be thought of as complex collections of different species of molecules. In the course of their metabolism, biological cells synthesize chemical compounds, and modify them in multifarious ways. Many of these products are released into the intercellular ... more

EMBL co-develops new method that could facilitate cancer diagnosis – faster, cheaper and more detailed

06-Jan-2020 Researchers led by the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Center for Bioinformatics at Saarland University in Saarbrücken, Germany, have developed a cheaper and faster method to check for genetic differences in individual cells, which outperforms existing tec ... more

Innovative method delivers new insights into the stem cell microenvironment – Bone marrow in 3D

02-Jan-2020 Researchers from the European Molecular Biology Laboratory (EMBL) and the German Cancer Research Center (DKFZ) in Heidelberg, Germany, have developed new methods to reveal the three-dimensional organisation of bone marrow at a single cell level. Since bone marrow harbours blood stem cells r ... more

Paper-based test could diagnose Lyme disease at early stages

20-Dec-2019 After a day hiking in the forest, the last thing a person wants to discover is a tick burrowing into their skin. Days after plucking off the bloodsucking insect, the hiker might develop a rash resembling a bull's-eye, a tell-tale sign of Lyme disease. Yet not everybody who contracts Lyme di ... more

New algorithm detects even the smallest cancer metastases across the entire mouse body

Exposing the enemy

16-Dec-2019 Teams at Helmholtz Zentrum München, LMU Munich and the Technical University of Munich (TUM) have developed a new algorithm that enables automated detection of metastases at the level of single disseminated cancer cells in whole mice. Cancer is one of the leading causes of death worldwide. M ... more

Fast and cheap low-tech method to test for the presence of any DNA sequence

10-Dec-2019 The student project DipGene developed a new methodology that makes genetic testing as easy as a pH-test. With their simple, cheap and low-tech method to test for the presence of any DNA sequence, they won a prestigious Gold Medal. A student team of the TU Dresden successfully showcased the ... more

Chip-based optical sensor detects cancer biomarker in urine

New technology lays groundwork for biosensors that improve disease diagnosis and monitoring

09-Dec-2019 For the first time, researchers have used a chip-based sensor with an integrated laser to detect very low levels of a cancer protein biomarker in a urine sample. The new technology is more sensitive than other designs and could lead to non-invasive and inexpensive ways to detect molecules t ... more

Deep learning identifies molecular patterns of cancer

04-Dec-2019 An artificial intelligence platform developed at the Max Delbrück Center for Molecular Medicine (MDC) can analyze genomic data extremely quickly, picking out key patterns to classify different types of colorectal tumors and improve the drug discovery process. The deeper analysis shows some ... more

Better diagnosis with 3D model of human liver tissue

Geometrical and functional liver model for improved diagnosis of non-alcoholic fatty liver disease

04-Dec-2019 Non-alcoholic fatty liver disease (NAFLD) is characterized by the accumulation of fat in the liver with an insulin resistance due to causes other than alcohol intake. NAFLD includes a spectrum of liver diseases from simple steatosis (“non-progressive” and reversible) to non-alcoholic steato ... more

The view through the bandage à la James Bond

Espionage for wound healing: On Your Medicine's Secret Service

28-Nov-2019 Whether a wound heals well under a dressing cannot be seen from the outside. Empa researchers are now enabling a view through the bandage à la James Bond. The refined application of terahertz radiation could promote the analysis of multi-layered tissues for medical purposes and be used for ... more

All news on diagnostics

Waters to Acquire Andrew Alliance

15-Jan-2020 Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

Eppendorf with new CEO dual leadership

Former CEO, Thomas Bachmann, left the company

10-Dec-2019 The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Business Area Sample Handling, as Co-Chief Executive Officers of Eppendorf AG. Both will succeed Thomas Bachmann, the former President & CEO of ... more

CEM acquires key assets of Intavis Bioanalytical Instruments

31-Oct-2019 CEM Corporation announced that it has entered into a definitive agreement to purchase the instrumentation lines of Intavis Bioanalytical Instruments AG, with headquarters in Cologne Germany. The acquisition allows CEM to strengthen its product offering in the Life Sciences for proteomics, i ... more

analytica 2020: The leading guide to the smart laboratory

The focus on digital transformation is being further expanded

28-Oct-2019 From March 31 to April 03, 2020, analytica will open its doors on the fairgrounds of Messe München. Even now there are already signs of an increase in the number of exhibitors. One focus of the world’s leading trade fair for laboratory technology, analysis and biotechnology with the accompa ... more

Sartorius signs agreement to acquire select Danaher Life Science platform businesses

21-Oct-2019 Sartorius has signed an agreement to acquire parts of Danaher’s Life Science Portfolio for approximately $750 million in cash. The businesses had combined sales turnover of approximately $140 million in 2018 with a strong growth profile and double-Digit profit margins. They employ around 30 ... more

Sartorius continues on its dynamic growth track

21-Oct-2019 Sartorius performed dynamically in the third quarter as well, achieving double-digit growth rates in sales revenue, order intake and earnings in the first nine months. “Sartorius achieved significant double-digit growth rates in sales revenue and earnings for the first nine months of the ye ... more

Eppendorf significantly expands production site in Oldenburg

27-Sep-2019 The Eppendorf Group is boosting its production capacity at its site in Oldenburg in Holstein by building two new production halls. Operations at the two sites will begin in the second half of 2020, significantly increasing the overall capacity of Eppendorf Polymere GmbH, a wholly owned subs ... more

ZEISS Opts for Continuity with New CEO

25-Sep-2019 At its meeting on 24 September 2019, the Supervisory Board of Carl Zeiss AG unanimously voted in favor of the following changes to the Executive Board: Dr. Karl Lamprecht, currently a Member of the Executive Board, will become the new President & CEO effective 1 April 2020. With this appoin ... more

New sample holder for protein crystallography

20-Sep-2019 An HZB research team has developed a novel sample holder that considerably facilitates the preparation of protein crystals for structural analysis. A short video by the team shows how proteins in solution can be crystallised directly onto the new sample holders themselves, then analysed usi ... more

Machine learning algorithm can't distinguish these lab mini-brains from preemie babies

03-Sep-2019 Brain organoids -- also called mini-brains -- are 3D cellular models that represent aspects of the human brain in the laboratory. Brain organoids help researchers track human development, unravel the molecular events that lead to disease and test new treatments. They aren't prefect replicas ... more

All news on laborausstattung / laborbedarf

A key to new drugs

Tiny metal-containing building block might become the core of new drug molecules

16-Jan-2020 A collaboration between research teams in Germany and the USA furnished a new concept for discovering drugs to treat life-threatening illnesses such as cancer, influenza, or multidrug resistant bacteria. The team proposes that three-dimensional metal-containing molecules may function as new ... more

Bayer and Exscientia collaborate to leverage the potential of artificial intelligence

10-Jan-2020 Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia’s proprietary AI drug discovery platform and drug design know- ... more

Bayer and Evotec form new strategic alliance focusing on polycystic ovary syndrome

Milestone payments potentially more than EUR 330 million

10-Jan-2020 Evotec SE and Bayer AG announced the expansion of their partnership in women’s health indications with a new five-year, multi-target collaboration to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (PCOS). Under the terms of the agreement, both companies ... more

Antibiotic tolerance reduces the ability to prevent resistance under drug combination therapies

10-Jan-2020 Antimicrobial tolerance can promote the evolution of antimicrobial resistance even under combination drug treatments widely used and expected to prevent it from occurring, a new study finds. The results suggest the need to consider drug tolerance when designing antibiotic treatments to prev ... more

Evotec and Bristol-Myers Squibb expand iPSC collaboration

08-Jan-2020 Evotec SE announced that the Company received a US$ 6 m payment from Bristol-Myers Squibb Company following the decision to expand the collaboration to include additional cell lines. Evotec and Celgene, which is now a Bristol-Myers Squibb company, initiated the collaboration in December 201 ... more

V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases

06-Jan-2020 V-Bio Ventures announced its investment in Augustine Therapeutics, a new venture developing innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. A spin-off of VIB and KU Leuven, Augustine raises a seed-round of 4.2 million euro with V-Bio Ventures, PMV, Advent Fr ... more

Evotec receives € 3 million payment from Sanofi

Evotec achieves third milestone in cell therapy diabetes alliance with Sanofi

20-Dec-2019 Evotec SE announced successful achievement of a third milestone in their diabetes research alliance with Sanofi (“TargetBCD”), resulting in a payment of € 3 m to Evotec. This milestone was triggered after Evotec met pre-agreed critical criteria within the beta cell replacement therapy progr ... more

Evotec expands service agreement with Sanofi to create a centralised global sample management hub in Toulouse

18-Dec-2019 Evotec SE announced plans to extend its sample management activities through an expansion of its service agreement with Sanofi. Evotec has had a successful track record of managing Sanofi’s powder compounds at its Toulouse site since 2015. Under the terms of the new agreement, Sanofi will t ... more

Separating Drugs with MagLev

Magneto-Archimedes levitation for identification of illicit drugs in powdered mixtures

11-Dec-2019 The composition of suspicious powders that may contain illicit drugs can be analyzed using a quick and simple method called magneto-Archimedes levitation (MagLev), according to a new study published in the journal Angewandte Chemie. A team of scientists at Harvard University, USA, has devel ... more

ImCheck Raises $53 Million Series B

05-Dec-2019 ImCheck Therapeutics, a biotech company developing a first-in-class antibody to activate gamma delta (γδ)T cells in a range of cancer indications and a portfolio of novel immunotherapies for the treatment of cancer and autoimmune diseases, announced the closing of a $53 million (€48 million ... more

All news on pharma

Induced pluripotent stem cells for the research of HIV and the innate immune system

17-Jan-2020 Jointly with researchers from Germany and France, researchers of the Paul-Ehrlich-Institut have generated induced pluripotent stem cells from one health individual, one patient with Aicardi-Goutières syndrome, and one patient with Renpenning syndrome. Proteins play a role in both diseases, ... more

A key to new drugs

Tiny metal-containing building block might become the core of new drug molecules

16-Jan-2020 A collaboration between research teams in Germany and the USA furnished a new concept for discovering drugs to treat life-threatening illnesses such as cancer, influenza, or multidrug resistant bacteria. The team proposes that three-dimensional metal-containing molecules may function as new ... more

First robust cell culture model for the hepatitis E virus

15-Jan-2020 A mutation switches the turbo on during virus replication. This is a blessing for research. Even though hepatitis E causes over three million infections and about 70,000 deaths each year, the virus has been little studied as yet. This may be about to change, because a research team from Boc ... more

Artificial Muscle Sheets Transform Stem Cells into Bone

Programmable biomaterials for bone regeneration introduced

15-Jan-2020 Specifically programmed materials can, under specific conditions, encourage stem cells to transform into bone cells – as revealed by a German research team under the leadership of the Helmholtz-Zentrum Geesthacht, Centre for Materials and Coastal Research. To do this, the scientists impleme ... more

How dying cells prevent dangerous immune reactions

14-Jan-2020 Dying cells in the body can keep the immune system in check, thus preventing unwanted immune responses against the body's own tissues. Scientists of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have now identified a receptor on immune cells that activates this ... more

What happens to deferred intentions in the brain?

14-Jan-2020 Placing a checkmark on the to-do list is an extremely liberating feeling for many eager list lovers, especially when the task has been postponed for a long time. But what happens in our brain when we have completed a postponed task? Will it be deactivated? If so, how? A team of scientists f ... more

Bacteria shredding tech to fight drug-resistant superbugs

14-Jan-2020 Researchers have used liquid metals to develop new bacteria-destroying technology that could be the answer to the deadly problem of antibiotic resistance. The technology uses nano-sized particles of magnetic liquid metal to shred bacteria and bacterial biofilm – the protective “house” that ... more

Unlimited potential: New ways to generate totipotent-like cells

13-Jan-2020 Totipotency is set to become a key tool for research and future medical applications. Finding efficient ways to generate totipotent-like cells is therefore crucial. In a new study, a group of researchers at Helmholtz Zentrum München found that totipotent-like cells can be induced by manipul ... more

Rejuvenating the brain

More stem cells improve learning and memory of old mice

13-Jan-2020 We all will experience it at some point, unfortunately: The older we get the more our brains will find it difficult to learn and remember new things. What the reasons underlying these impairments are is yet unclear but scientists at the Center for Regenerative Therapies of TU Dresden (CRTD) ... more

Emergence of calorie burning fat cells

A new approach to treating overweight and obesity

10-Jan-2020 1.9 billion people in the world are overweight. Of these, 650 million people are obese, which increases the risk of secondary diseases such as high blood pressure or cancer. Professor Martin Klingenspor and his team at the Technical University of Munich (TUM) examine how our fat metabolism ... more

All news on healthcare
News by department
  • Products

    BioMed X completes Alzheimer’s disease research project

    29-Oct-2019 BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease. BioMed X received a milestone payment and the results of the project were transferred to AbbVie. The BioMed X team su ... more

    Using algorithms to track down cancer

    08-Aug-2019 Modern medicine is looking for markers that provide early warning of complex diseases. In its quest to discover these “biomarkers”, the ETH spinoff Scailyte has developed software capable of analysing millions of single cells very efficiently. The search for biomarkers is currently one of t ... more

    Nordic Nanovector: European Patent Granted for Betalutin or Humalutin in Combination With Anti-CD20 Antibodies for Treating NHL

    04-Jun-2019 Nordic Nanovector ASA announces that the European Patent Organisation (EPO) has granted the company's European Patent covering the use of Betalutin® or Humalutin® in combination with anti-CD20 antibodies for the treatment of non-Hodgkin's lymphoma (NHL). The same patent has also been issued ... more

  • Business

    Cunesoft joins forces with Phlexglobal

    16-Jan-2020 The Munich-based Cunesoft GmbH, an provider of cloud-based intelligent regulatory data management software and services for the life sciences industry, announced that it has been acquired by Phlexglobal from current investors including Bayern Kapital, High-Tech Gründerfonds and OCCIDENT. Ph ... more

    Waters to Acquire Andrew Alliance

    15-Jan-2020 Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

    V-Bio Ventures invests in Augustine Therapeutics, a VIB and KU Leuven spin-off to fight neuromuscular diseases

    06-Jan-2020 V-Bio Ventures announced its investment in Augustine Therapeutics, a new venture developing innovative therapeutics for patients suffering from Charcot-Marie-Tooth disease. A spin-off of VIB and KU Leuven, Augustine raises a seed-round of 4.2 million euro with V-Bio Ventures, PMV, Advent Fr ... more

  • Price Development

    Drug costs vary by more than 600% in study of 10 high-income countries

    13-Jun-2017 In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%. All countries except Canada offered universal coverage of outpatient prescription drugs. The study looked at dat ... more

    Cell Medica granted Orphan Drug designation for novel cellular therapy

    18-Mar-2015 Cell Medica announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s cancer immunotherapy treatment, referred to as CMD-003, under development for Epstein-Barr Virus (EBV) positive non-Hodgkin lymphomas. Additionally, the company announ ... more

    BASF increases prices for Vitamin E and A feed grade

    14-Nov-2013 BASF increases prices for Vitamin E and A products for animal nutrition globally and with immediate effect. Prices will increase by 15% for all Vitamin E products and by 10% for all Vitamin A products. Existing contractual obligations with customers will be honored. more

  • Research

    Watching complex molecules at work

    17-Jan-2020 A new method of infrared spectroscopy developed at BESSY II makes single-measurement observation and analysis of very fast as well as irreversible reaction mechanisms in molecules feasible for the first time. Previously, thousands of such reactions have had to be run and measured for this p ... more

    Induced pluripotent stem cells for the research of HIV and the innate immune system

    17-Jan-2020 Jointly with researchers from Germany and France, researchers of the Paul-Ehrlich-Institut have generated induced pluripotent stem cells from one health individual, one patient with Aicardi-Goutières syndrome, and one patient with Renpenning syndrome. Proteins play a role in both diseases, ... more

    Bacteria and sand engineered into living concrete

    17-Jan-2020 Cement and concrete haven't changed much as technology in over a hundred years, but researchers in Colorado are revolutionizing building materials by literally bringing them to life. The method developed, presented January 15 in the journal Matter, combines sand and bacteria to build a livi ... more

  • People

    Change on the Bachem Corporate Executive Committee

    13-Dec-2019 Bachem announced that Dr. Thomas Früh will be stepping down as CEO on health grounds effective January 1, 2020. Dr. Früh will continue to serve the company in a corporate services role. His successor as CEO will be current Chief Operations Officer (COO) and Corporate Executive Committee mem ... more

    Eppendorf with new CEO dual leadership

    Former CEO, Thomas Bachmann, left the company

    10-Dec-2019 The Supervisory Board of Eppendorf AG has appointed Eva von Pelt, currently Chief Commercial Officer, and Dr. Peter Fruhstorfer, currently Head of Business Area Sample Handling, as Co-Chief Executive Officers of Eppendorf AG. Both will succeed Thomas Bachmann, the former President & CEO of ... more

    Change at the top of the Management Board of BRAIN AG

    03-Dec-2019 The company announces, that the Supervisory Board appointed Adriaan Moelker to the Management Board with effect from 1 February 2020 and appointed him as the future Chairman of the Board (CEO). Dr Jürgen Eck, co-founder of BRAIN, Chief Technology Officer (CTO) for around 26 years as well as ... more

  • Finances

    Tenth Record-Breaking Year in a Row for ZEISS

    Revenue increases by 11 percent to 6.4 billion euros

    13-Dec-2019 The ZEISS Group continued its growth trajectory, with revenue and earnings reaching new heights in fiscal year 2018/19, which ended 30 September 2019. Revenue grew by 11 percent, reaching 6.428 billion euros (previous year: 5.817 billion euros). Adjusted for currency and acquisition effects ... more

    Removal Of Tumor Cells From Surgical Blood

    Over 5 Million Euros For Lindis Blood Care

    12-Dec-2019 As is standard during tumor surgeries, when large volumes of blood are lost, donor blood is given to the patient. Worldwide, this is the case for more than half a million tumor surgeries annually. This procedure can result in many serious side effects and increased tumor recurrence rates. H ... more

    Inscripta raised $125M in Series D round

    Accelerate Commercialization of Revolutionary Digital Genome Engineering Platform

    11-Dec-2019 Inscripta, Inc. announced the company has raised $125 million in a Series D financing with support from the company’s existing investors and new investors JS Capital Management LLC and Oak HC/FT. Paladin Capital Group led the round, bringing the total amount raised by the company to $259.5 ... more

  • Cooperation

    Bayer and Exscientia collaborate to leverage the potential of artificial intelligence

    10-Jan-2020 Bayer and Exscientia Ltd., a UK-based Artificial Intelligence (AI)-driven drug discovery company, have entered into a three-year, multi-target collaboration. The partners will work on early research projects combining Exscientia’s proprietary AI drug discovery platform and drug design know- ... more

    Bayer and Evotec form new strategic alliance focusing on polycystic ovary syndrome

    Milestone payments potentially more than EUR 330 million

    10-Jan-2020 Evotec SE and Bayer AG announced the expansion of their partnership in women’s health indications with a new five-year, multi-target collaboration to develop multiple clinical candidates for the treatment of polycystic ovary syndrome (PCOS). Under the terms of the agreement, both companies ... more

    Evotec and Bristol-Myers Squibb expand iPSC collaboration

    08-Jan-2020 Evotec SE announced that the Company received a US$ 6 m payment from Bristol-Myers Squibb Company following the decision to expand the collaboration to include additional cell lines. Evotec and Celgene, which is now a Bristol-Myers Squibb company, initiated the collaboration in December 201 ... more

  • Technology

    Printing nanoparticle shapes for medical applications

    18-Apr-2019 Personal drug delivery or nano-robotic systems could be a key concept for future medical applications. In this context, scientists around David Ng (Department of Prof. Tanja Weil) of the Max Planck Institute for Polymer Research (MPI-P) have recently developed a technology to customize the ... more

    BioMCN to produce renewable methanol with green hydrogen

    27-Feb-2019 Nouryon (formerly AkzoNobel Specialty Chemicals) and Gasunie have agreed to supply green hydrogen to BioMCN for the production of renewable methanol from CO2. The companies say it marks the next step in the sustainability of processes in the industry. Nouryon and Gasunie are currently inves ... more

    Growth factors in single cells counted for the first time

    26-Feb-2019 Whether healthy or diseased, human cells exhibit behaviors and processes that are largely dictated by growth factor molecules, which bind to receptors on the cells. For example, growth factors tell the cells to divide, move, and when to die--a process known as apoptosis. When growth factor ... more

  • Laws

    Japan and Singapore Grant CRISPR Patents to Merck

    27-Nov-2019 Merck announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed the company’s patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide. “Paired nickases represent a significant step in incre ... more

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

    05-Mar-2019 Merck announced that the Canadian Patent Office has allowed Merck’s patent application directed to the use of paired CRISPR nickases in eukaryotic cells. The patent provides an important and more specific solution for scientists who need accurate methods when developing treatments for diffi ... more

  • Market

    Many of the deadliest cancers receive the least amount of research funding

    'Embarrassing' or stigmatized cancers like lung and liver are underfunded

    23-Jul-2019 Many of the deadliest or most common cancers get the least amount of nonprofit research funding, according to a new Northwestern Medicine study that examined the distribution of nonprofit research funding in 2015 across cancer types. Colon, endometrial, liver and bile duct, cervical, ovaria ... more

    Gene Editing Tools Gain an Uptick in Sales With Emphasis on Rare Genetic Disorder Management

    22-Jul-2019 According to latest research by FMI, the global gene editing tools market is estimated to have accounted for more than US$ 258 Mn in terms of value in 2018. The report on the gene editing tools market further projects that the gene editing tools market is likely to grow at a CAGR of over 18 ... more

    Merck announces the winners of its Advance Biotech Grant program

    Merck Awards Grants to Biotechs Focused on Traumatic Brain Injury, Vaccine Development and Chronic Pain

    31-May-2019 Merck announced the winners of its Advance Biotech Grant program in North America during its Biotech Start-up Summit at the Cambridge Innovation Center (Massachusetts, U.S.). The grant is given to small- and mid-size biotechnology companies that need funding and expertise to get their thera ... more

  • Politics

    Restriction of hazardous substances in tattoo inks

    15-Mar-2019 ECHA’s Committee for Socio-economic Analysis (SEAC) adopted its final opinion supporting the proposal by Denmark, Italy, Norway and ECHA to restrict the placing on the market of tattoo inks and permanent make-up. Substances within the scope of the restriction include carcinogenic, mutagenic ... more

    ECETOC Task Force provides new insights

    Toxicity testing of microparticles and poorly soluble liquids in the water environment

    15-Jan-2019 A Task Force set up by the European Centre for Ecotoxicology and Toxicology of Chemicals (ECETOC) has provided new insights into scientific testing for the impact of undissolved particles in the aquatic environment. ECETOC launched the Task Force in response to increasing concerns among the ... more

    15 emerging technologies that could reduce global catastrophic biological risks

    11-Oct-2018 Strategic investment in 15 promising technologies could help make the world better prepared and equipped to prevent future infectious disease outbreaks from becoming catastrophic events. This subset of emerging technologies and their potential application are the focus of a new report, Tech ... more

  • Manufacturing

    Eppendorf significantly expands production site in Oldenburg

    27-Sep-2019 The Eppendorf Group is boosting its production capacity at its site in Oldenburg in Holstein by building two new production halls. Operations at the two sites will begin in the second half of 2020, significantly increasing the overall capacity of Eppendorf Polymere GmbH, a wholly owned subs ... more

    Lonza Expands Bioconjugation Facility and Announces Approval of Third Commercial ADC

    24-Jul-2019 Lonza announced the start of expansion to its bioconjugation facility in Visp, Switzerland together with the successful commercial approval of a third antibody-drug-conjugate (ADC) produced at the site. Building on 12 years of experience in the exacting bioconjugation space, Lonza’s expansi ... more

    FUJIFILM Irvine Scientific constructs new cell culture media manufacturing site in Europe

    03-Jul-2019 FUJIFILM Irvine Scientific, Inc. announced plans to open a third manufacturing facility located in Tilburg, Netherlands. The company currently has sites in the United States and Japan. Fujifilm’s investment in this project demonstrates its commitment to accelerate development in bioproducti ... more

  • Career

    Eppendorf with worldwide setting program

    Around 250 vacancies at all locations by the end of 2019

    26-Apr-2019 The Eppendorf Group is creating around 250 new jobs worldwide this year. A large proportion of the new jobs will be created in Hamburg at the headquarters of the globally active life sciences company and is an important component of Eppendorf's growth strategy. "Eppendorf is growing strongl ... more

    Lower pension, shorter life

    12-Apr-2019 Income and social status have an increasing effect on life expectancy in Germany. On average, men with very low retirement pay die five years earlier than those who are much better off. Poverty shortens life. According to a study by researchers at the Max Planck Institute for Demographic Re ... more

    KNAUER among the top one percent of employers in Germany

    28-Feb-2019 In the study "Leading Employers Germany 2019", the Berlin-based manufacturer of high-tech laboratory measuring instruments KNAUER was ranked as one of the best employers for the second time. This makes KNAUER one of the companies with the best ratings in an independent meta-study conducted ... more

News according to country
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE